Coagulation cascade simplify

Reading File

Finding Sources

Searching PubMed

coagulation cascade

Searching the Web

coagulation cascade intrinsic extrinsic common pathway Merck Manual

Coagulation cascade, simplified

Goal: make a strong fibrin mesh that stabilizes the initial platelet plug.

Think of it as:

Injury → factor activation chain → thrombin → fibrin clot

1. Primary hemostasis first

A vessel is injured:

Blood vessel constricts
Platelets stick to the damaged area and form a quick, temporary plug

Then the coagulation cascade reinforces it with fibrin.

2. Two pathways start the cascade

Pathway	Trigger	Key factors	Lab test
Extrinsic	Tissue injury exposes tissue factor (III)	VII	PT/INR
Intrinsic	Blood contacts damaged/abnormal surface	XII, XI, IX, VIII	aPTT

Easy mnemonic

Extrinsic = 7
Intrinsic = 12, 11, 9, 8
Common = 10, 5, 2, 1

3. Both meet at the common pathway

Extrinsic: tissue factor + VII
                    ↓
Intrinsic: XII → XI → IX + VIII
                    ↓
              Factor X activated
                    ↓
               Xa + Va
                    ↓
      Prothrombin (II) → Thrombin (IIa)
                    ↓
     Fibrinogen (I) → Fibrin
                    ↓
       Factor XIII cross-links fibrin
                    ↓
           Stable blood clot

The high-yield core

Factor X becomes Xa. Xa converts prothrombin to thrombin.
Thrombin converts fibrinogen to fibrin.
Fibrin forms the stable clot.

Why thrombin matters

Thrombin (factor IIa) is the main worker:

Converts fibrinogen to fibrin
Activates factors V, VIII, XI, and XIII
Activates platelets
Amplifies clot formation

Real-life note

The traditional intrinsic/extrinsic diagram is useful for exams and interpreting lab tests, but in the body, clotting usually begins when tissue factor is exposed after injury, then thrombin amplifies the process. - Tietz Textbook of Laboratory Medicine, coagulation section

Clinical links

Warfarin reduces vitamin K-dependent factors: II, VII, IX, X. It mainly prolongs PT/INR.
Heparin enhances antithrombin, inhibiting mainly IIa (thrombin) and Xa. Unfractionated heparin prolongs aPTT.
Hemophilia A: factor VIII deficiency, intrinsic pathway, prolonged aPTT.
Hemophilia B: factor IX deficiency, intrinsic pathway, prolonged aPTT.
Factor XIII deficiency: a clot may initially form but is poorly stabilized because fibrin cannot be properly cross-linked.

One-line memory aid

“7 starts it, 10 joins it, 5 helps it, 2 makes thrombin, 1 makes fibrin, 13 locks it.”

Create a one-page coagulation cascade cheat sheet

Reading File

Finding Sources

Searching PubMed

blood coagulation cascade

Searching the Web

coagulation cascade intrinsic extrinsic common pathway laboratory tests PT aPTT official

Generating Image

A one-page study cheat sheet titled “COAGULATION CASCADE”. Include a clean accurate flow diagram: vessel injury leads to platelet plug (primary hemostasis), then two secondary-hemostasis paths. Extrinsic pathway: Tissue factor (III) + VII → X. Intrinsic pathway: XII → XI → IX + VIII → X. Common pathway: X + V → II (prothrombin) → IIa (thrombin) → I (fibrinogen) → fibrin; XIII cross-links fibrin to make a stable clot. Include a lab-test box: PT/INR tests extrinsic + common and aPTT tests intrinsic + common. Include a memory box: ‘Extrinsic: 7. Intrinsic: 12, 11, 9, 8. Common: 10, 5, 2, 1, 13.’ Include a clinical box: Hemophilia A = VIII deficiency, Hemophilia B = IX deficiency, warfarin affects II, VII, IX, X, heparin enhances antithrombin against IIa and Xa. Make every arrow and factor label large, legible, and high contrast for printing.

One-page coagulation cascade cheat sheet

Fast recall:
7 starts the extrinsic pathway.
12, 11, 9, 8 are intrinsic.
10, 5, 2, 1, 13 form and stabilize the fibrin clot.

PT/INR assesses the extrinsic + common pathway, while aPTT assesses the intrinsic + common pathway. - NCBI clotting-test guide

Create a coagulation cascade vs anticoagulants comparison table

Reading File

Finding Sources

Searching PubMed

anticoagulants factor Xa thrombin

Searching the Web

anticoagulant reversal agents warfarin heparin direct thrombin factor Xa FDA

Coagulation cascade vs anticoagulants

Cascade target	Normal role in clotting	Anticoagulant class	Examples	How it works	Monitoring / reversal
Vitamin K-dependent factor production: II, VII, IX, X	Provides several factors needed across the cascade	Vitamin K antagonist	Warfarin	Decreases hepatic synthesis of functional factors II, VII, IX, X	PT/INR monitoring. Reversal: vitamin K, with 4-factor PCC for major bleeding
Antithrombin	Natural inhibitor of thrombin and Xa	Unfractionated heparin (UFH)	Heparin	Potentiates antithrombin, inhibiting mainly IIa (thrombin) and Xa	aPTT or anti-Xa. Reversal: protamine
Factor Xa, indirectly	Xa forms the prothrombinase complex with Va and converts II to IIa	LMWH	Enoxaparin, dalteparin	Antithrombin-mediated inhibition, mainly of Xa	Usually no routine test; anti-Xa in selected cases. Protamine gives partial reversal
Factor Xa, indirectly	Same Xa step	Indirect Xa inhibitor	Fondaparinux	Antithrombin-mediated, selective Xa inhibition	Usually no routine test; protamine does not reverse it reliably
Factor Xa, directly	Xa converts prothrombin to thrombin	Direct oral Xa inhibitors	Apixaban, rivaroxaban, edoxaban	Directly inhibits Xa, reducing thrombin generation	Routine PT/aPTT is unreliable for drug level. Specific reversal: andexanet alfa for apixaban/rivaroxaban in appropriate major bleeding settings
Thrombin (IIa)	Converts fibrinogen (I) into fibrin	Direct thrombin inhibitor, oral	Dabigatran	Directly inhibits thrombin	aPTT may suggest presence but is not a precise measure. Reversal: idarucizumab
Thrombin (IIa)	Same final fibrin-forming enzyme	Parenteral direct thrombin inhibitors	Argatroban, bivalirudin	Direct thrombin inhibition	aPTT commonly used. No routinely used specific antidote
Fibrin formation	Thrombin converts fibrinogen to fibrin; XIII cross-links it	No major standard drug directly targets fibrinogen or XIII	-	Most anticoagulants act upstream by reducing Xa or thrombin activity	-

Put it onto the cascade

Intrinsic:  XII → XI → IX + VIII
                         ↓
Extrinsic: Tissue factor + VII
                         ↓
                       X → Xa  ← LMWH, fondaparinux, apixaban/rivaroxaban/edoxaban
                         ↓
               II (prothrombin) → IIa (thrombin)  ← UFH, dabigatran, argatroban, bivalirudin
                         ↓
             I (fibrinogen) → fibrin → XIII cross-linked stable clot

Warfarin lowers production of: II, VII, IX, X

Exam shortcuts

Warfarin: decreases 2, 7, 9, 10; check PT/INR.
UFH: inhibits 2a and 10a through antithrombin; check aPTT.
LMWH: predominantly inhibits 10a through antithrombin.
DOAC Xa inhibitors: end in -xaban and inhibit Xa.
Dabigatran: direct thrombin (IIa) inhibitor.
Antiplatelet drugs such as aspirin or clopidogrel are different: they impair the platelet plug in primary hemostasis, rather than the coagulation-factor cascade.

Heparin enhances antithrombin activity against thrombin and factor Xa, while oral agents include warfarin, dabigatran, and Xa inhibitors such as apixaban, rivaroxaban, and edoxaban. - Henry's Clinical Diagnosis and Management by Laboratory Methods, key points; Harrison's Principles of Internal Medicine, anticoagulants

For laboratory interpretation, PT evaluates the extrinsic and common pathways, whereas aPTT evaluates the intrinsic and common pathways, as summarized in this NCBI reference.

This is a shared conversation. Sign in to Orris to start your own chat.